Partner Therapeutics (PTx) is a commercial biotech committed to improving the lives of patients with cancer and other serious diseases.

Joined October 2017
🧠 Sponsor Spotlight: @PartnerTx On #NationalHealthcareDecisionsDay, we recognize the importance of informed, timely trauma care. Thanks to @PartnerTx for advancing immunotherapy that supports decision-making in critical trauma settings. 🌐 partnertx.com #THOR #RDCR
1
1
170
Announcing the PAP Education Day Travel Reimbursement Program! We're offering patients travel reimbursement up to a set amount for those who could not otherwise attend the Michigan Education Day on a first-come, first-served basis. Apply here: forms.gle/XG9eQWon4CfzC3VY6
4
4
Dr. Isabel Lauren Jackson from @UMmedschool spoke to @CNNBusiness about Leukine, a drug developed to help in the recovery of white blood cells following chemotherapy or radiation therapy. cnn.com/2022/03/29/business/…
2
3
New Research: The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review: Autoantibodies to multiple cytokines have been identified and some, including antibodies against… frontiersin.org/articles/10.… #immunology
8
1
17
Announcing a brand new PAP CME program! Share with your PAP clinicians! Link : mycme.com/courses/know-how-t…
1
3
UK reopening delay underlines the need to learn to live with Covid-19 - londonlovesbusiness.com/uk-r…
1
1
1
PartnerTx retweeted
Ian Kremer@LEAD_Coalition21 Jun 2021
22
32
Just published ⁦@fsgimt⁩ Part of our assessment of #immunotherapy triplet combination candidates. We review #rhuGMCSF preclinical, clinical & translational data & the underlying mechanisms supporting enhanced efficacy & reduced immune toxicity futuremedicine.com/doi/10.22…
4
5
#TannerGAP fields international inquiries & works w/physicians, hospitals & ministries of health to provide medicine that is not currently available in their country. Learn more about our services and the Leukine Access Program (LeAP): tannerpharma.com/our-impact/…
2
2
Biogen spent $1 billion on neuro drug candidates, the Longwood Fund launched a new incubator and another biotech planned an IPO this week. Did you catch all of the news? Read it here, in The Petri Dish.​ bizjournals.com/boston/news/…
Conference in the time of Corona with #ASGCT20! Thank you to these wonderful faces (clockwise fr top L): co-chair Debasish Roychowdhury @PartnerTx, Delfi Krishna @GSK, Rogerio Vivaldi @Sigilon_Inc, co-chair @katyspinkdhcg, Katherine Tsokas @JanssenGlobal, and John Doyle @pfizer.
3
5
The @PAP_Foundation officially supports inhaled GM-CSF therapy as a treatment for aPAP patients and encourages FDA approval! Read more and see the full press release here: bit.ly/2Jmz1Ml
1
2
6